Neupro Related Clinical Trials
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro� Requiring Caregiver Support [Completed]
Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Repeated Dose Transdermal Rotigotine in Japanese and Caucasian Subjects [Completed]
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects [Completed]
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body [Completed]
Study in Healthy Volunteers to Prove That Two Rotigotine Patches From Different Manufacturing Sites Deliver Equivalent Drug Amount to the Body [Completed]
Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects [Completed]
Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body. [Completed]
Trial to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine in Healthy Korean Subjects [Completed]
The Use of Rotigotine for Treatment of Reducing Signs and Symptoms of Fibromyalgia in Adults. [Completed]
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Rotigotine Transdermal Patch in Healthy Chinese Subjects [Completed]
Trial to Assess Parkinson's Disease (PD) Symptom Control to Four Doses of Rotigotine in a Transdermal Patch [Completed]
Named Patient Program With Rotigotine Transdermal System [Completed]
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction [Terminated]
Switching From Oral Dopamine Agonists to Rotigotine [Active, not recruiting]
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of Parkinson Symptoms [Completed]
Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine [Completed]
Long-term Extension of RECOVER- Long-term Effect of the 24h Transdermal Delivery of Rotigotine in Subjects With Idiopathic Parkinson's Disease [Terminated]
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease [Completed]
Cardiac Effects of Rotigotine Transdermal System in Subjects With Advanced-stage Idiopathic Parkinson's Disease [Completed]
An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease [Completed]
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS) [Completed]
A Trial of Neupro� (Rotigotine Transdermal Patch) in Patients With Parkinson's Disease Undergoing Surgery [Completed]
A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease [Completed]
A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease [Completed]
A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis [Completed]
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease [Completed]
Study to Assess Dopamine Receptor Modulation With Rotigotine to Enhance Morphine Analgesia in the Dental Model [Not yet recruiting]
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Early-Stage Parkinson's Disease. [Completed]
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease [Completed]
Change in Gastrointestinal Complaints After Switch From Oral Parkinson's Disease Treatment to Neupro® Transdermal Patch [Completed]
Placebo-controlled Study in Patients With Parkinson's Disease to Evaluate the Effect of Rotigotine on Non-motor Symptoms [Completed]
Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine [Completed]
Single-site, Open-label, Randomized, Cross-over Study in Healthy Chinese Subjects to Evaluate the Bioequivalence of Single-dose Rotigotine Transdermal Patch Comparing 2 Different Formulations [Completed]
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease [Completed]
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise [Completed]
Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome [Completed]
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome [Completed]
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms [Completed]
Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's Disease [Terminated]
Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations [Completed]
Trial to Evaluate The Efficacy Of Rotigotine on Parkinson's Disease-Associated Motor Symptoms And Apathy [Completed]
Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients [Completed]
Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients [Completed]
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation [Completed]
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients [Completed]
Long-term Open-label Trial in Idiopathic Restless Legs Syndrome (RLS) [Completed]
Observational Study With Neupro® to Evaluate the Patient´s Perception of Pain Associated With Parkinson´s Disease [Completed]
Study to Evaluate the Efficacy of Rotigotine on Parkinson's Disease-Associated Pain [Completed]
MIRT and Rotigotine in the Early Stage of PD [Recruiting]
Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment [Not yet recruiting]
Non-interventional, Retrospective, Multi-center Study to Evaluate Non-motor Symptoms in Advanced Parkinson Disease (PD) Patients Already Treated With Rotigotine [Completed]
Transdermal Rotigotine User Surveillance Study [Completed]
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome [Active, not recruiting]
Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke [Completed]
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease [Recruiting]
A Trial To Assess Switching From Ropinirole, Pramipexole Or Cabergoline To The Rotigotine Transdermal System In Idiopathic Parkinson's Disease [Completed]
Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects [Completed]
Pharmacokinetics and Safety Study of LY03003 in Patients With Early-stage Parkinson's Disease [Recruiting]
Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome [Completed]
An Extension Trial to Investigate Long-Term Treatment With Transdermal Rotigotine in Idiopathic Restless Legs Syndrome [Completed]
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome [Completed]
A Trial to Evaluate the Effects of Rotigotine Transdermal Patch on Early Morning Motor Impairment and Sleep Disorders Idiopathic Parkinson's Disease [Completed]
A Sleep Lab Trial to Investigate the Efficacy and Safety of Transdermal Rotigotine in Subjects With Idiopathic Restless Legs Syndrome [Completed]
A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease [Completed]
Rotigotine Restless Legs Syndrome Dose Finding Trial [Completed]
Measuring the Effects of Continuous Dopaminergic Stimulation on Nocturnal Movements in Parkinson's Disease [Recruiting]
Explorative Open Label Study of Efficacy Profile of Neurexan® in Experimental Acute Stress Setting in Healthy Subjects [Completed]
Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects [Completed]
Treatment of Parkinson's Disease With a Transdermal Skin Patch [Completed]
A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients [Completed]
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients [Completed]
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients [Completed]
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients [Completed]
A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome [Completed]
Butrans for Treatment of Restless Legs Syndrome [Withdrawn]
Infusion of Apomorphine: Long-term Safety Study [Recruiting]
A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject [Completed]
A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients [Completed]
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients [Completed]
A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients [Completed]
50 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Parkinson's Disease [Completed]
|